Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SR-BI-directed HDL-cholesteryl ester hydrolysis.

Margery A Connelly1, Ginny Kellner-Weibel, George H Rothblat

  • 1Department of Pharmacological Sciences, University Medical Center, State University of New York at Stony Brook, Stony Brook, NY 11794-8651, USA. connelly@pharm.sunysb.edu

Journal of Lipid Research
|February 11, 2003
PubMed
Summary

This study explored how two receptors, SR-BI and CD36, handle HDL-CE in cells. Researchers found that SR-BI is more effective at delivering HDL-CE to a neutral pathway for hydrolysis, while CD36 does not perform this function as well. They tested different cell types and found that the hydrolysis of HDL-CE occurs in a membrane-bound compartment. For LDL-CE, both receptors delivered it for hydrolysis, but SR-BI used a neutral enzyme while CD36 used an acidic one. The study suggests that SR-BI plays a unique role in HDL metabolism and that the hydrolysis pathway depends on the receptor and cell type.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines.

Nature immunology·2026
Same author

Gold-containing compounds target an apicomplexan Thioredoxin reductase: Disclosing reactivity through structural and functional characterization.

International journal of biological macromolecules·2026
Same author

Examination of Coligands in Mefloquine-Metal Complexes Reveals the Structural Determinants of Activity against <i>Plasmodium falciparum</i> and <i>Schistosoma mansoni</i>.

Journal of medicinal chemistry·2026
Same author

Unravelling the anti-cancer mechanisms elicited by non-covalent thioredoxin reductase inhibitors for triple negative breast cancer therapy.

Redox biology·2026
Same author

Mycobacterial α-glucans hijack dectin-1 to facilitate intracellular bacterial survival.

Science immunology·2026
Same author

Heme drives cardiac endothelial senescence in sepsis via STING activation.

Cell death & disease·2025

Area of Science:

  • Lipid metabolism research within cell biology
  • Receptor-mediated transport in endocrinology
  • HDL function studies in cardiovascular medicine

Background:

Prior research has shown that scavenger receptors mediate lipid uptake, but the specific roles of SR-BI and CD36 in cholesteryl ester (CE) metabolism remain unclear. Established knowledge indicates that HDL and LDL differ in their receptor interactions. However, the exact pathways through which SR-BI and CD36 direct HDL-CE hydrolysis have not been fully resolved. No prior work had resolved whether these receptors deliver HDL-CE to distinct metabolic compartments. This gap motivated further investigation into the receptor-specific mechanisms of CE processing. Researchers propose that SR-BI may uniquely facilitate HDL-CE hydrolysis via a neutral pathway. That uncertainty drove comparative studies using multiple cell types and receptor models. The findings may clarify how HDL-CE is processed in different tissues.

Purpose Of The Study:

The aim of this study was to determine how SR-BI and CD36 influence the hydrolysis of HDL-CE in cells. The specific problem addressed is the lack of clarity regarding the receptor-specific pathways for HDL-CE metabolism. The motivation stems from the need to understand how these receptors direct CE to different metabolic compartments. The researchers sought to compare SR-BI and CD36 in terms of HDL-CE uptake and hydrolysis. They also aimed to identify the enzyme responsible for CE hydrolysis in each pathway. The study focused on whether SR-BI can direct HDL-CE to a neutral CE hydrolase. The motivation included investigating whether cell type influences hydrolytic activity. The goal was to determine if SR-BI functions differently from CD36 in HDL metabolism.

Keywords:
HDL metabolismScavenger receptor functionNeutral CE hydrolaseLipid transport mechanisms

Frequently Asked Questions

SR-BI directs HDL-CE to a neutral CE hydrolase pathway, while CD36 does not.

Hydrolysis was measured using a neutral CE hydrolase and inhibitor studies in multiple cell types.

It shows that HDL-CE hydrolysis occurs in a metabolically active membrane compartment.

LDL-CE is hydrolyzed via neutral or acidic pathways depending on the receptor.

Y1-BS1 adrenal, Fu5AH hepatoma, and transfected cells were used.

Related Experiment Videos

Main Methods:

The study compared SR-BI and CD36 in their ability to direct HDL-CE hydrolysis. Researchers used cells expressing SR-BI and CD36 to assess uptake and hydrolysis rates. They employed a neutral CE hydrolase to evaluate the enzyme activity in each receptor pathway. Inhibitor sensitivities were tested in Y1-BS1, Fu5AH, and transfected cells. The researchers measured hydrolysis of HDL-CE and LDL-CE separately. They analyzed whether the receptors delivered CE to distinct metabolic pathways. Membrane fractions were isolated to determine where hydrolysis occurred. The study used comparative analysis to distinguish SR-BI and CD36 functions.

Main Results:

SR-BI delivered HDL-CE with greater uptake and faster hydrolysis compared to CD36. Hydrolysis of HDL-CE via both receptors occurred through a neutral CE hydrolase. SR-BI, but not CD36, efficiently directed HDL-CE to a neutral hydrolytic pathway. LDL-CE was delivered and hydrolyzed equally well by SR-BI and CD36. Hydrolysis of LDL-CE via SR-BI occurred through a neutral CE hydrolase. In contrast, CD36 delivered LDL-CE via an acidic CE hydrolase. Inhibitor studies showed cell type-specific differences in HDL-CE hydrolysis. HDL-CE hydrolytic activity was found in membrane fractions of Y1-BS1 cells.

Conclusions:

The authors suggest that SR-BI can efficiently direct HDL-CE to a neutral CE hydrolytic pathway. They propose that CD36 does not perform this function as effectively. The findings indicate that SR-BI and CD36 deliver HDL-CE to different metabolic compartments. The researchers suggest that SR-BI may facilitate HDL-CE hydrolysis in a membrane-bound compartment. They propose that the hydrolytic activity is cell type-specific. The authors suggest that HDL-CE hydrolysis occurs in a metabolically active membrane fraction. They suggest that SR-BI and CD36 differ in their delivery of LDL-CE to acidic or neutral pathways. The authors conclude that SR-BI plays a unique role in HDL-CE metabolism.

SR-BI efficiently delivers HDL-CE to a neutral hydrolytic pathway.